Cancer research: what’s new and how it affects your care

Research in cancer moves fast. New drugs, genetic tests, and trial designs change treatment options every year. You don’t need a PhD to use that info. This page gives clear, practical points so you can ask better questions, spot useful trials, and make informed choices with your doctor.

Where the biggest advances are

Immunotherapy is one of the biggest shifts: drugs that help your immune system attack tumors. Some cancers respond extremely well; others less so. CAR‑T cell therapy reprograms a patient’s own immune cells and works well for certain blood cancers. Targeted therapies focus on specific mutations — for example, EGFR or ALK inhibitors for lung cancer — and can lead to big responses if your tumor has the matching change.

Precision medicine and tumor sequencing (NGS tests) look for those actionable mutations. If a test finds BRCA, HER2, KRAS, or other markers, it can open drug options or trials. Liquid biopsies — blood tests that detect tumor DNA — are getting better for monitoring response and spotting recurrence earlier than scans in some cases.

How to use research when making decisions

Want to find a trial or decide between treatments? Start with these practical steps.

- Ask your oncologist about genetic testing and whether your tumor has targets that match approved drugs or trials. If they don’t offer testing, ask where to get it.

- Search ClinicalTrials.gov or talk to your hospital’s research team. Look for trial phase: phase I tests safety, phase II looks at activity, and phase III compares to standard care. Phase III results carry the strongest evidence for changing practice.

- Read trial endpoints: overall survival (OS) and progression‑free survival (PFS) mean different things. OS shows if people live longer; PFS shows if the cancer stays controlled longer. Side effects matter as much as benefit—ask about quality of life data.

- Prepare for logistics: trial visits, extra scans, and possible travel can add time and cost. Check whether your insurer covers tests and visits outside standard care. Ask about financial support from the study center.

- Get a second opinion if a recommended treatment is experimental or if multiple options exist. A second view can clarify priorities: extending life, preserving function, or symptom control.

- Know your rights: informed consent explains risks, benefits, and alternatives. You can leave a trial at any time. Ask who to call about side effects and how quickly they’ll respond.

Research doesn’t promise cures for everyone, but it expands options. Use tests to personalize care, check trial design before signing up, and bring a clear list of questions to every visit. If you want, I can help draft questions for your oncologist or find trials that match a specific diagnosis and test result.

By Barrie av / Jun, 26 2023

The Impact of Alpelisib on Cancer Research and Drug Development

As a blogger who is passionate about advancements in cancer research, I've been closely following the impact of Alpelisib on the field. This breakthrough drug has shown promising results in treating hormone receptor-positive, HER2-negative advanced breast cancer, specifically in patients with PIK3CA mutations. The success of Alpelisib has not only provided new hope for patients but has also paved the way for more targeted therapies in cancer treatment. Additionally, it has encouraged further research into similar drugs and their potential applications in other cancer types. Overall, Alpelisib's impact on cancer research and drug development has been truly remarkable and I'm excited to see what the future holds.

view more